CRISM Therapeutics Corporation (AIM:CRTX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
11.67
+0.42 (3.73%)
Jul 9, 2025, 12:18 PM GMT+1
-25.90%
Market Cap 4.50M
Revenue (ttm) 25.00K
Net Income (ttm) -607.00K
Shares Out 39.96M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 36,572
Average Volume 103,990
Open 11.35
Previous Close 11.25
Day's Range 11.35 - 12.00
52-Week Range 5.64 - 29.40
Beta 0.23
RSI 22.26
Earnings Date Jun 19, 2025

About CRISM Therapeutics

CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporati... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 4
Stock Exchange London Stock Exchange AIM
Ticker Symbol CRTX
Full Company Profile

Financial Performance

In 2024, CRISM Therapeutics's revenue was 25,000, a decrease of -44.44% compared to the previous year's 45,000. Losses were -607,000, 209.7% more than in 2023.

Financial Statements

News

AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence

Mobile Tornado, MediaZest, Pri0r1ty Intelligence are today's top risers, while Crism Therapeutics, Versarien take the biggest fall on AIM

8 days ago - The Armchair Trader

AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy

Surface Transforms, AFC Energy, Empyrean are today's top risers, while Argentex, Crism Therapeutics take the biggest fall on London's AIM

2 months ago - The Armchair Trader